Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Markets / Stock Markets/  Pandemic pets push industry stocks to pricey valuations
BackBack

Pandemic pets push industry stocks to pricey valuations

wsj

Veterinary services firm Idexx Laboratories, drug company Zoetis are among the year’s big winners

FILE- In this April 5, 2018, file photo a sign for a Wall Street subway station is shown. Wall Street is strengthening again as big technology stocks wrest back more of their losses from their sudden belly flop earlier this month. The S&P 500 was 0.9% higher in early trading and back within 5% of its record set on Sept. 2, 2020. (AP Photo/Richard Drew, File) (AP)Premium
FILE- In this April 5, 2018, file photo a sign for a Wall Street subway station is shown. Wall Street is strengthening again as big technology stocks wrest back more of their losses from their sudden belly flop earlier this month. The S&P 500 was 0.9% higher in early trading and back within 5% of its record set on Sept. 2, 2020. (AP Photo/Richard Drew, File) (AP)

The pet business has been among the great beneficiaries of the new coronavirus. That success has made some stocks in the sector expensive.

Among the sector’s big winners this year are veterinary services firm Idexx Laboratories, up about 61% this year, and drug company Zoetis Inc., which is 25% higher. The S&P 500 is up 8.7% for 2020. Investors will get a closer look at the companies in the coming weeks: Idexx is due to report third-quarter results Oct. 29, while Zoetis is due to report its results Nov. 5.

The pandemic has been accompanied by an uptick in pet ownership. A corresponding rise in the use of medicine and diagnostic tests for pandemic puppies and other pets is boosting revenue at animal-health companies. As working-from-home arrangements become more permanent for some, workers have more time to care for pets.

Michael Ryskin, an equity analyst at Bank of America, said he believes these trends will amount to a multiyear tailwind for the animal-health industry.

“The pet, or ‘companion animal’ industry, has been incredibly strong and resilient for many years, and despite fear of a negative impact from Covid-19, is having another strong year in 2020," he said.

This quarter Mr. Ryskin said he would be watching for whether the economic recession is curtailing some pet owners’ spending, though he doesn’t expect that to be the case.

Given the strength of the companies’ stocks, investors will have to consider the risk of buying shares that trade at a premium to the rest of the market.

Shares of Zoetis, are trading at about 40 times estimated 2021 earnings, said Jefferies analyst David Steinberg. Idexx trades at about 62 times 2021 expected earnings, Mr. Ryskin said. The S&P 500 trades at about 26 times expected earnings over the next 12 months, according to FactSet.

Mr. Steinberg said strong initial sales and the potential of Zoetis’s Simparica Trio medicine, which protects animals against heartworm and other diseases, help justify the valuation. The company’s highly anticipated feline-pain medication, which is expected to launch sometime in 2021, is another revenue driver to watch, he said.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Next Story footLogo
Recommended For You
GENIE RECOMMENDS

Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!

Let’s get started
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie